Acuta Capital Partners’s Oxford Immunotec Global OXFD Stock Holding History
Bought
Maintained
Sold
Other funds holding OXFD
Acuta Capital Partners's OXFD Position: Q2 2017 in Review
Acuta Capital Partners sold out of Oxford Immunotec Global (OXFD) in Q2 2017, closing a stake of 386,100 shares — an estimated $5.98M sold.
Acuta Capital Partners first reported a position in OXFD in Q1 2015 and held it in 9 quarters. The position peaked at $7.04M in Q4 2016. 75 funds tracked by Wall St. Rank hold OXFD as of Q2 2017.
- Acuta Capital Partners reported no remaining Oxford Immunotec Global position as of Q2 2017 after selling out during the quarter.
- Acuta Capital Partners sold 386,100 Oxford Immunotec Global shares in Q2 2017, an estimated $5.98M.
- Acuta Capital Partners first reported a position in Oxford Immunotec Global in Q1 2015 and held it in 9 quarters.
- Acuta Capital Partners's Oxford Immunotec Global position peaked at $7.04M in Q4 2016.
- 75 funds tracked by Wall St. Rank held Oxford Immunotec Global as of Q2 2017.
Based on Acuta Capital Partners's 13F filing for Q2 2017, filed 14 Aug 2017.